1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow CS1001+ Fluorouracil+Cisplatin: new trials by email Literature Review of CS1001+ Fluorouracil+Cisplatin trials Research Report on CS1001+ Fluorouracil+Cisplatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma CS1001+ Fluorouracil+Cisplatin, Placebo+ Fluorouracil+Cisplatin - Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma | Phase 3 | Completed | CStone Pharmaceuticals | 540 | 2019-12-19 | 2023-11-24 |
Esophageal Squamous Cell Carcinoma (1) · Recurrence (1)
China (1)